OGC
TDOC icon

Oak Grove Capital’s Teladoc Health TDOC Stock Holding History

Oak Grove Capital’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$1K – 117
2021
Q2 		$1K Hold
100
– – ﹤0.01% 111
2021
Q1 		$2K Hold
100
– – ﹤0.01% 100
2020
Q4 		$3K Buy
+100
New +$20.3K ﹤0.01% 83

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Oak Grove Capital's TDOC Position: Q1 2022 in Review

Oak Grove Capital sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 12,028 shares — an estimated $1.1M sold.

Oak Grove Capital first reported a position in TDOC in Q2 2020 and held it in 7 quarters. The position peaked at $6.47M in Q4 2020. 679 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Oak Grove Capital reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Oak Grove Capital sold 12,028 Teladoc Health shares in Q1 2022, an estimated $1.1M.
  • Oak Grove Capital first reported a position in Teladoc Health in Q2 2020 and held it in 7 quarters.
  • Oak Grove Capital's Teladoc Health position peaked at $6.47M in Q4 2020.
  • 679 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Oak Grove Capital's 13F filing for Q1 2022, filed 10 May 2022.